DelveInsight: One Year Anniversary!
Feb 27, 2015
Thanks to our great Clients, Partners, Colleagues, Family and Friends, we’re celebrating the completion of our first year in business.
Thanks for helping to make DelveInsight a success!!
Downloads
Article in PDF
Recent Articles
- Amgen’s IMDELLTRA FDA Approval; J&J’s Proteologix Acquisition; Bristol Myers Squibb’s B...
- DelveInsight’s Discount on Market Research Reports!
- Prolong’s PP-007 Fast-Tracked for Stroke; FDA Expands JYLAMVO Pediatric Approval; Corcept’s Cushi...
- Cellectis successfully bags USD 164 million for Gene-editing and CAR-T programs
- DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports
Downloads
Article in PDF
Recent Articles
- HER2 Expression and its Dynamic Functional States
- Isocitrate dehydrogenase (IDH) inhibitors– Emerging Anti-Cancer Therapeutics
- Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets
- Acute Myeloid Leukemia: Market Dynamics, Epidemiology, and Future Projections
- FDA Grants Orphan Status to MDL-101 for LAMA2-CMD; Pfizer’s ABRYSVO Approved for High-Risk Adults...
